{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:07:40Z","timestamp":1791846460481,"version":"4.3.4"},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.2967\/jnumed.125.271467","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:35:15Z","timestamp":1775140515000},"page":"1125-1131","source":"Crossref","is-referenced-by-count":2,"title":["Dosimetry Analysis of\n                    <sup>177<\/sup>\n                    Lu-PSMA-I&amp;T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial"],"prefix":"10.2967","volume":"67","author":[{"given":"Zachary","family":"Ells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Wilhalme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius B.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Unterrainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sennung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejah","family":"Nabong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca F.","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Czernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Dahlbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar U.","family":"Kishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Calais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2026070106450730000_67.7.1125.1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(24)01653-2","article-title":"177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial","volume":"404","author":"Morris","year":"2024","journal-title":"Lancet."},{"key":"2026070106450730000_67.7.1125.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026070106450730000_67.7.1125.3","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-014-0315-z"},{"key":"2026070106450730000_67.7.1125.4","doi-asserted-by":"crossref","first-page":"20200496","DOI":"10.1259\/bjr.20200496","article-title":"Stereotactic body radiotherapy (SBRT) in metachronous oligometastatic prostate cancer: a systematic review and meta-analysis on the current prospective evidence","volume":"93","author":"Yan","year":"2020","journal-title":"Br J Radiol."},{"key":"2026070106450730000_67.7.1125.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4853"},{"key":"2026070106450730000_67.7.1125.6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol."},{"key":"2026070106450730000_67.7.1125.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00644"},{"key":"2026070106450730000_67.7.1125.8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4298"},{"key":"2026070106450730000_67.7.1125.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.183194"},{"key":"2026070106450730000_67.7.1125.10","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.eururo.2018.11.016","article-title":"Treatment outcome, toxicity, and predictive factors for radioligand therapy with 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer","volume":"75","author":"Heck","year":"2019","journal-title":"Eur Urol."},{"key":"2026070106450730000_67.7.1125.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30198-0"},{"key":"2026070106450730000_67.7.1125.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00237-3"},{"key":"2026070106450730000_67.7.1125.13","doi-asserted-by":"crossref","first-page":"863101","DOI":"10.3389\/fnume.2022.863101","article-title":"An update to the pilot study of 177Lu-PSMA in low volume hormone-sensitive prostate cancer","volume":"2","author":"Priv\u00e9","year":"2022","journal-title":"Front Nucl Med."},{"key":"2026070106450730000_67.7.1125.14","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1200\/JCO-25-01553","article-title":"177Lu-prostate-specific membrane antigen neoadjuvant to stereotactic ablative radiotherapy for oligorecurrent prostate cancer (LUNAR): an open-label, randomized, controlled, phase II study","volume":"43","author":"Kishan","year":"2025","journal-title":"J Clin Oncol."},{"key":"2026070106450730000_67.7.1125.15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bju.15988","article-title":"LUNAR: a randomized phase 2 study of 177lutetium-PSMA neoadjuvant to ablative radiotherapy for oligorecurrent prostate cancer (clinical trial protocol)","volume":"132","author":"Ma","year":"2023","journal-title":"BJU Int."},{"key":"2026070106450730000_67.7.1125.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.211094"},{"key":"2026070106450730000_67.7.1125.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268520"},{"key":"2026070106450730000_67.7.1125.18","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00259-018-4136-7","article-title":"EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations","volume":"45","author":"Gear","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026070106450730000_67.7.1125.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267452"},{"key":"2026070106450730000_67.7.1125.20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MNM.0000000000001658","article-title":"Kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry","volume":"44","author":"Uijen","year":"2023","journal-title":"Nucl Med Commun."},{"key":"2026070106450730000_67.7.1125.21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00259-021-05471-4","article-title":"Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome","volume":"49","author":"Peters","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026070106450730000_67.7.1125.22","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90171-Y"},{"key":"2026070106450730000_67.7.1125.23","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1200\/JCO-25-00131","article-title":"Outcomes of radium-223 and stereotactic ablative radiotherapy versus stereotactic ablative radiotherapy for oligometastatic prostate cancers: the RAVENS phase II randomized trial","volume":"43","author":"Wang","year":"2025","journal-title":"J Clin Oncol."},{"key":"2026070106450730000_67.7.1125.24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ijrobp.2025.06.3869","article-title":"177Lu-PSMA-617 SPECT\/CT dosimetry and radiobiological models demonstrate decreasing tumor-to-kidney dose ratio with successive cycles","volume":"123","author":"Fitzpatrick","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2026070106450730000_67.7.1125.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)01455-X"},{"key":"2026070106450730000_67.7.1125.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.053173"},{"key":"2026070106450730000_67.7.1125.27","first-page":"44","article-title":"Partial volume effect in SPECT & PET imaging and impact on radionuclide dosimetry estimates","volume":"11","author":"Marquis","year":"2023","journal-title":"Asia Ocean J Nucl Med Biol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:05:34Z","timestamp":1782914734000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.2967\/jnumed.125.271467"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271467","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}